Gainers
- Ainos, Inc. AIMD shares surged 55.1% to $2.1411 after the company reported results from the additional preclinical study of its low-dose oral interferon formulation against Omicron. The company reported VELDONA formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period.
- F45 Training Holdings Inc. FXLV shares jumped 43.1% to $3.1350 after a 13D filing showed the company received a non-binding proposal offer by one or more funds for a value of $4 per share.
- InMed Pharmaceuticals Inc. INM gained 39.9% to $8.03. InMed recently reported a FY22 net loss of $33.17 per share.
- SOBR Safe, Inc. SOBR jumped 39.3% to $2.6884 after the company announced it signed three reseller agreements with national distributors.
- MoneyLion Inc. ML rose 28% to $1.02. MoneyLion responded to Consumer Financial Protection Bureau’s meritless complaint.
- FingerMotion, Inc. FNGR surged 23.1% to $2.2778.
- O2Micro International Limited OIIM rose 22.8% to $3.9901 after the company announced it entered into a definitive agreement for a "going private" transaction.
- Avenue Therapeutics, Inc. ATXI shares gained 22.6% to $8.89. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
- IGM Biosciences, Inc. IGMS rose 18.9% to $23.11.
- X4 Pharmaceuticals, Inc. XFOR gained 18.8% to $1.77. X4 Pharmaceuticals recently announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
- Benson Hill, Inc. BHIL rose 18.3% to $2.9250 after UBS initiated coverage on the stock with a Buy rating and $5 price target.
- Tyra Biosciences, Inc. TYRA jumped 17.7% to $10.33.
- Alset EHome International Inc. AEI gained 17.3% to $0.2299.
- Snow Lake Resources Ltd. LITM surged 16.7% to $1.8215. Snow Lake Resources issued filing showing the company has requested for withdrawal of registration statement in regards to its previously announced public offering.
- Nocera, Inc. NCRA jumped 16.2% to $1.58. Nocera recently entered into agreement to acquire 51% controlling interest in iTake Inc. in Taiwan.
- Ecoark Holdings, Inc. ZEST gained 14.8% to $1.47.
- SAI.TECH Global Corporation SAI rose 14.6% to $2.59 after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
- Solid Biosciences Inc. SLDB gained 14.4% to $0.5355 after the company announced acquisition of AavantiBio and a concurrent $75 million private placement.
- Akero Therapeutics, Inc. AKRO rose 14.3% to $34.06. Akero Therapeutics recently released topline data from HARMONY Phase 2b study of efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), fibrosis stage 2 or 3 (F2-F3).
- IonQ, Inc. IONQ gained 13.3% to $5.41after the company announced it secured a contract to provide quantum solutions to the U.S. Air Force Research Lab.
- Immuneering Corporation IMRX jumped 12.6% to $14.77. Immuneering announced FDA clearance of IND application for Phase 1/2a clinical trial of IMM-1-104 to treat advanced solid tumors with RAS mutations.
- bluebird bio, Inc. BLUE gained 12.2% to $6.39. bluebird bio recently named Katherine Breedis as interim CFO.
- Foghorn Therapeutics Inc. FHTX jumped 11.2% to $9.13.
- MINISO Group Holding Limited MNSO surged 11% to $5.53. MINISO Group’s board of directors recently authorized and approved a new share repurchase program.
- Daseke, Inc. DSKE gained 10.5% to $5.41 after the company announced a $40 million stock repurchase program.
- Iveda Solutions, Inc. IVDA rose 9.9% to $0.67 after declining over 6% on Thursday. Iveda Solutions, last month, announced a $5 million private placement.
- Kura Oncology, Inc. KURA gained 9.2% to $14.53. Kura Oncology, last month, posted a Q2 loss of $0.52 per share.
- Paysafe Limited PSFE gained 8.8% to $1.48.
- Charles River Laboratories International, Inc. CRL gained 7.6% to $204.46 after Jefferies upgraded the stock from Hold to Buy and announced a $240 price target.
- WISeKey International Holding AG WKEY rose 7.3% to $1.6101.
- First Wave BioPharma, Inc. FWBI rose 6.2% to $1.54.
Losers
- Antelope Enterprise Holdings Limited AEHL shares dipped 36.7% to $0.57 after the company announced pricing of a $1 million registered direct offering.
- American Virtual Cloud Technologies, Inc. AVCT fell 36.4% to $ 0.1899. AVCT announced intent to effect reverse stock split.
- SHF Holdings Inc SHFS fell 23% to $6.73 after declining 15% on Thursday. Northern Lights Acquisition completed business combination of SHF, Safe Harbor Financial, which offers compliance services to financial institutions that serve the regulated cannabis industry.
- 5E Advanced Materials Inc. FEAM dropped 22.8% to $10.82.
- Aterian, Inc. ATER fell 20.3% to $1.5708 after the company priced a 10,526,368 share registered direct offering at $1.90 per share
- Carnival Corporation CCL fell 19% to $6.73 after the company reported worse-than-expected Q3 EPS and sales results.
- Panbela Therapeutics, Inc. PBLA dropped 17.8% to $0.2951 after the company priced a common stock offering of 20.1 million shares at $0.30 per share.
- Rent-A-Center Inc RCII fell 17.3% to $18.46 as the company lowered its earnings guidance for the third quarter and named Mr. Fahmi Karam as new Executive Vice President - Chief Financial Officer.
- Powerbridge Technologies Co., Ltd. PBTS dipped 16.1% to $0.4997.
- Intercept Pharmaceuticals, Inc. ICPT shares fell 15% to $13.96 after the company announced its REVERSE Phase 3 study of obeticholic acid did not meet its primary endpoint.
- OpGen, Inc. OPGN fell 15% to $0.3201 after the company announced a $3.38 million registered direct offering.
- TH International Ltd THCH declined 12.7% to $6.36.
- Norwegian Cruise Line Holdings Ltd. NCLH dropped 12% to $12.21 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
- Century Aluminum Company CENX dipped 12% to $5.68 after Wolfe Research downgraded the stock from Peer Perform to Underperform.
- NIKE, Inc. NKE fell 10.5% to $85.28. NIKE reported better-than-expected earnings and sales results for its first quarter on Thursday. However, the company reported a rise in quarter-ended inventories and revenue in the Greater China region also declined from a year ago.
- Ocular Therapeutix, Inc. OCUL dropped 10.3% to $4.60. Ocular Therapeutix 10%+ owner Summer Road LLC reported purchase of 150,000 at an average price of $4.59 per share in Form 4 filing on Thursday.
- Royal Caribbean Cruises Ltd. RCL fell 8.7% to $39.84 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
- Amylyx Pharmaceuticals, Inc. AMLX fell 5% to $28.69 as the stock pulled back after gaining following FDA approval of RELYVRIO for ALS..
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasCommunications EquipmentInformation TechnologyMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in